Amphastar Pharmaceuticals (AMPH) Operating Income (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Operating Income of $13.6 million for Q1 2026, down 63.45% year-over-year from $37.3 million in Q1 2025, and down 61.72% quarter-over-quarter from $35.6 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Operating Income (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Operating Income history runs 14 years deep, the most recent figure standing at $13.6 million for Q1 2026.
- In Q1 2026, Operating Income fell 63.45% year-over-year to $13.6 million; the TTM figure through Mar 2026 stood at $116.7 million (down 40.04% YoY), while the FY2025 annual figure was $140.4 million, down 31.65% from the prior year.
- Operating Income for Q1 2026 stood at $13.6 million, down from $35.6 million in the prior quarter.
- The five-year high for Operating Income was $72.7 million in Q3 2023, with the low at $13.6 million in Q1 2026.
- The 5-year median for Operating Income is $37.3 million (2025), against an average of $39.1 million.
- The sharpest annual moves came in 2023 and 2026: Operating Income surged 212.89% in 2023, then plunged 63.45% in 2026.
- Amphastar Pharmaceuticals' Operating Income stood at $37.8 million in 2022, then soared by 42.68% to $54.0 million in 2023, then fell by 16.37% to $45.1 million in 2024, then fell by 21.13% to $35.6 million in 2025, then slumped by 61.72% to $13.6 million in 2026.
- Business Quant data shows AMPH's Operating Income at $13.6 million in Q1 2026, $35.6 million in Q4 2025, and $25.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 936.60 Mn | 646.48 Mn | 93.47 Mn | 39.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39.73 Mn |
| Mar 31, 2026 | 13.63 Mn |
| Dec 31, 2025 | 35.61 Mn |
| Sep 30, 2025 | 25.32 Mn |
| Jun 30, 2025 | 42.18 Mn |
| Mar 31, 2025 | 37.29 Mn |
| Dec 31, 2024 | 45.14 Mn |
| Sep 30, 2024 | 57.05 Mn |
| Jun 30, 2024 | 55.22 Mn |
| Mar 31, 2024 | 48.01 Mn |
| Dec 31, 2023 | 53.98 Mn |
| Sep 30, 2023 | 72.68 Mn |
| Jun 30, 2023 | 36.90 Mn |
| Mar 31, 2023 | 33.43 Mn |
| Dec 31, 2022 | 37.83 Mn |
| Sep 30, 2022 | 23.23 Mn |
| Jun 30, 2022 | 24.82 Mn |
| Mar 31, 2022 | 21.61 Mn |
| Dec 31, 2021 | 24.25 Mn |
| Sep 30, 2021 | 24.77 Mn |